Clinical trials
Phase 1/2 Adenocarcinoma, Mucinous trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 1 |
| M.D. Anderson Cancer Center | 1 |
| University Health Network, Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma, Mucinous | 3 |
| Carcinosarcoma | 1 |
| Cystadenocarcinoma, Serous | 1 |
| Fallopian Tube Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Ovarian Neoplasms | 1 |
| Pancreatic Neoplasms | 1 |
| Uterine Cervical Neoplasms | 1 |
| Uterine Neoplasms | 1 |
| Vaginal Neoplasms | 1 |
Trials
Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.